First Patient Dosed in BeCoMe-9 Trial of BE-101 for Hemophilia B - Hematology Advisor

Retrieved on: 2025-08-26 13:58:14

Tags for this article:

Click the tags to see associated articles and topics

First Patient Dosed in BeCoMe-9 Trial of BE-101 for Hemophilia B - Hematology Advisor. View article details on hiswai:

Excerpt

... Biopharma. As the first B-cell medicine designed to insert the human factor IX (FIX) gene into primary human B cells, BE-101 aims to provide ...

Article found on: www.hematologyadvisor.com